Published online Sep 16, 2022. doi: 10.4253/wjge.v14.i9.555
Peer-review started: April 16, 2022
First decision: May 12, 2022
Revised: May 21, 2022
Accepted: August 10, 2022
Article in press: August 10, 2022
Published online: September 16, 2022
Processing time: 151 Days and 10.2 Hours
Single balloon enteroscopy (SBE) allows ease of access for small bowel visualization and has multiple diagnostic and therapeutic indications. It provides the advantage of performing various therapeutic interventions alongside the diag
To investigate the indications, safety, and clinical yield of SBE, and determine its effect on disease outcome.
A retrospective, descriptive study was conducted at a tertiary care hospital in Karachi, Pakistan. Medical records of 56 adult patients (≥ 18 years) who under
A total of 56 patients who underwent 61 SBE procedures were included. The mean age was 50.93 ± 16.16 years, with 53.6% of them being males. Hypertension (39.3%) and diabetes mellitus (25.0%) were the most common pre-existing com
SBE is a suitable modality for investigating diseases in the small bowel. It is shown to be technically efficient and reasonably safe and is associated with high diagnostic and therapeutic yield.
Core Tip: Single balloon enteroscopy (SBE) is a safe and effective modality which allows ease of access for small bowel visualization. The procedure has multiple diagnostic and therapeutic indications. However, there is insufficient data published reporting its efficacy and impact. In this study, we analysed our single centre data of adults who underwent SBE between 2013 and 2021. We report patient demographics, procedure indications, and procedure findings. Based on our results, we can assess the indications, safety, and clinical yield of SBE, and determine its effect on disease outcome.